Microbial world
Microbes make up a startling 90 percent of the cells in our bodies. But because the vast majority are difficult or impossible to grow in the lab, the details of this microscopic menagerie have largely remained a mystery.
That’s changing, thanks to faster, cheaper sequencing technologies, which allow scientists to explore our microbial inhabitants more closely than ever before. A slew of new papers in Nature, Science, and three journals from the Public Library of Science — PLoS ONE, PLoS Computational Biology and PLoS Genetics — published in the last two weeks report the first results from the Human Microbiome Project, a five-year, multi-institute effort, funded by the National Institutes of Health, to comprehensively catalog our microbes.
Having this catalog will allow scientists to assess how microbial profiles are altered in different disorders, including autism. Some studies have reported changes in the microbial profiles of some children with autism, for example, which might help explain the high incidence of gastrointestinal complaints associated with the disorder.
For the Human Microbiome Project, researchers collected samples from 242 healthy people ranging in age from 18 to 40, from up to 18 different body sites, targeting five main body areas — the airways, skin, oral cavity, digestive tract and vagina. They took samples from each person up to three times over nearly two years.
The researchers found more than 5 million microbial genes, a number that dwarfs the approximately 20,000 genes in the human genome. That genetic complexity hints at the myriad roles these microbes play in our health.
The studies also found that the types of microbes can vary widely from site to site on the body and from person to person. But even though the microbes vary among individuals, their overall function — breaking down energy sources, for example — is similar from person to person, the researchers say.
Microbes also have a role in immune function, which has been implicated in autism as well.
Children with autism are thought to have different microbial populations than controls have, including a family of bacteria called Alcaligenaceae, and abnormally high levels of Clostridium bacteria. Some species of Alcaligenaceae are harmful to humans, causing whooping cough, for example. But it’s not yet clear how these microbes affect children with autism.
Children with autism have also been reported to have higher concentrations of P-cresol, a toxic compound produced by microbes, including Clostridium.
Moreover, animal research suggests that our microbial inhabitants can influence brain development and behavior. Mice raised without microbes have different patterns of gene expression in the brain and are more hyperactive than controls.
In all these studies, however, it’s unclear whether the differences cause the symptoms or are a result of having the disorder. New tools developed as part of the Human Microbiome Project, along with a baseline map of microbial variability, should allow researchers to better characterize the microbiome in autism and understand how it contributes to the disorder.
This article has been modified from the original. It has been changed to reflect the fact that the studies of the microbiome in children were not part of the Human Microbiome Project.






Comments
Very happy to see that the first results from the Human Microbiome Project have been picked up here. The whole area of the gut microbiota offers so many new avenues for research into autism and lots of other conditions with the important caveats about association and causation.
Two important additions to add to the bacteria-autism story so far:
(1) Findings from antimicrobial administration in cases of autism; thinking specifically about Richard Sandler's finding quite a few years back with vancomycin. Not promoting this or anything but certainly some suggestion that bacterial eradication might have some knock on effects...
(2) The possible link between gut bacteria and gut permeability; as per the Sutterella findings (specifically antibodies to Sutterella) and how permeability issues may further complicate the story somewhat.
Bravo for this post!
Excellent!! I wholeheartedly agree with Paul Whitely, and would like to add the best, if not the only way, to find out 'whether the differences (in microbiome in autism) cause the symptoms or are a result of having the disorder' is to carry out large scale treatment trials with various antimicrobial agents. I believe one is under way in France. We need more of those, and urgently.
I am thrilled to see this research and so glad Simons is covering this issue. Behavioral interventions do not work for children like mine until their GI disease is addressed. We really must prioritize this issue because this type of treatment research will greatly improve the quality of of life for ASD children living and suffering now. PANDAS is a perfect example of why OCD behavior can be immunologically driven. It would be great to see Simons get more involved in this life changing here and now research. I have figured out the medical interventions my son needs but parents are really on their own here- we need help via treatment research.
Fellow readers may recall that John Walker-Smith was the pioneer of work surrounding the importance of the GI tract , which is a large part of the Human Microbiome. What is often overlooked is that he and fellow gastroenterologists were able to successfully "treat' ASD symptomatology by addressing the GI Issues.
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2805%2970323-8/fulltext